#United States #New York #Securities Class Action #Rosen Law #Disc Medicine

Rosen Law Firm Investigates Disc Medicine, Inc.

The Rosen Law Firm, a well-known global firm representing investor rights, has begun an investigation into possible securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON). The firm is looking into allegations that Disc Medicine may have provided misleading business information that could have influenced investor decisions.

Background on the Investigation

This investigation stems from an important event that occurred on February 13, 2026, when the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Disc Medicine regarding one of its notable projects, the bitopertin program. The FDA’s communication indicated that Disc’s New Drug Application (NDA) could not be approved due to certain uncertainties that necessitated additional evidence. This news had a dramatic effect on Disc Medicine’s stock, which plummeted by approximately 22% on the same day.

Investors who may have purchased Disc Medicine securities before this fall are urged to consider their rights to potentially recoup their losses. Rosen Law Firm is ready to represent these investors in a proposed class action lawsuit, where they may be entitled to compensation without any upfront costs or fees due to the contingency fee arrangement.

What Investors Should Do

If you are a shareholder of Disc Medicine, you are encouraged to reach out to the Rosen Law Firm for detailed information on how to join this prospective class action. Interested parties can visit their website here or contact attorney Phillip Kim directly via phone at 866-767-3653 or through email at [email protected].

Choosing the right legal representation is crucial in such situations. The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a proven track record in securities litigation. Unlike many firms that may not actively engage in litigating securities class actions, Rosen Law Firm has achieved noteworthy success, including the largest securities class action settlement against a Chinese company. Moreover, they have consistently ranked highly for the number of settlements secured each year, having obtained billions of dollars for investors.

The Firm’s Qualifications

Rosen Law Firm has notable accolades; in 2017, they were ranked number one by ISS Securities Class Action Services for the number of securities class action settlements achieved. Furthermore, their founding partner, Laurence Rosen, has been recognized as a Titan of the Plaintiffs' Bar by Law360 in 2020, reinforcing the firm’s credibility and expertise in this sector. Many attorneys within the firm have received recognition from prestigious legal publications, further showcasing their skill in protecting investor rights.

For further updates regarding this investigation or other announcements, both current and potential clients can follow Rosen Law Firm on their social media channels, including LinkedIn, Twitter, and Facebook.

Conclusion

As the investigation into Disc Medicine, Inc. unfolds, it is critical for investors to stay informed and take proactive steps to safeguard their interests. With the exemplary history and success record of the Rosen Law Firm, investors have a reliable ally in pursuing claims against misleading information that may have impacted their investments. Don’t hesitate to take the necessary steps to reclaim your rights today.